13 – 15 October 2026
Hall 1, Messe Basel
Discovery • Development • Clinical Trials • Manufacturing • Market Access • Fill & Finish
-
13 – 15 October 2026
-
-
13 – 15 October 2026
Hall 1, Messe BaselDiscovery • Development • Clinical Trials • Manufacturing • Market Access • Fill & Finish
EUROPE'S LARGEST BIOLOGICS EVENT
3,000
Attendees
380
Speakers
150
Exhibitors
100
Start-Ups
About Festival of Biologics
The Festival of Biologics Basel is Europe’s largest biologics event, covering the start-to-finish of the industry in antibody therapies, cell and gene therapies, immunotherapies and biosimilars. Designed for industry experts in pharma and biotech, start-ups, academics, regulators and investors, the Festival of Biologics is the meeting place for the large molecule therapy ecosystem, bringing together 3000+ attendees.
Join 350 world class speakers in exploring the latest research in early stage discovery, modality engineering, translational medicine, clinical trials, manufacturing, commercialisation and fill/finish operations across key therapy and disease areas. With three days of presentations, panels, roundtables and workshops, this event is the place to be to keep up with the latest advances across the entire biologics and ATMP value chain.
Speaker line-up
Andreas Pluckthun
Professor of Biochemistry
University of Zurich
Professor of Biochemistry
University of Zurich
Attendees include
Sponsors & Exhibitors
Diamond Sponsor
Diamond Sponsor
Diamond Sponsor
Diamond Sponsor
Diamond Sponsor
Platinum Sponsor
Platinum Sponsor
Gold Sponsor
Gold Sponsor
Gold Sponsor
Gold Sponsor
Gold Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Bronze Sponsor
Bronze Sponsor
Bronze Sponsor
Bronze Sponsor
Bronze Sponsor
Bronze Sponsor
Bronze Sponsor
Bronze Sponsor
Bronze Sponsor
Bronze Sponsor
Bronze Sponsor
Bronze Sponsor
Bronze Sponsor
Bronze Sponsor
Bronze Sponsor
Exhibitor
Partner
Exhibitor
Exhibitor
Startup
Startup
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Silver Sponsor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Bronze Sponsor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Silver Sponsor
Exhibitor
Exhibitor
Exhibitor
Bronze Sponsor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Partner
Exhibitor
Silver Sponsor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Partner
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Startup
Startup
Startup
Startup
Startup
Startup
Startup
Startup
Startup
Startup
Startup
Startup
Startup
Startup
Startup
Startup
Startup
Startup
Startup
Startup
Startup
Startup
Startup
Startup
Startup
Startup
Startup
Startup
Startup
Startup
Startup
Startup
Startup
Startup
What is the Festival of Biologics?
Conference
The start to finish of biologic drug development from discovery through to market access across 3 days and 13 tracks
Exhibition
150 leading solution providers to meet your needs across discovery, development, manufacturing, fill finish and market access
Networking
Connect with thousands of biologics experts in 12+ hours of built-in 1-2-1 networking
New For 2026
Space and Microgravity Environments
With launch costs being driven lower and lower, low earth orbit is finally accessible to an increasing number of industries. Join our keynote panel discussion to explore how innovative companies, national agencies, regulators, and drug developers are coming together to take advantage of the unique environment that space can offer for protein crystalisation and formulation.
Industry and Strategy
In a turbulent post-COVID world, the pharmaceutical industry needs to adapt to changes in supply chains, recruitment, and a rapidly evolving regulatory environment across the largest markets. With presentations examining finding and retaining talent, insights from emerging markets, building a robust and sustainable supply chain, and working with external partners, this session provides a key overview of the latest strategies driving the industry.
Therapeutic Peptide and GLP Engineering
Peptides and peptide analogues have risen to prominence in recent years, with GLP1 therapies bringing groundbreaking results in diabetes and obesity. The Festival of Biologics brings together experts in peptide and analogue engineering, analytics and manufacturing, as well as exploring recent successes and the potential for other disease areas.
2026 Keynotes
Day 1
Advancing Biosimilars in the European and Global Markets
Antibody-Based Products: Successes & Progresses in 2026
Plenary Panel Discussion: The Next Frontier: Integrating Next-Gen Science with Sustainable
Commercial Models in Cell Therapy
Day 2
Bispecific and multispecific antibodies: An overview of development trends and the current clinical pipeline
Plenary Panel Discussion: Advancing Biologics in Non-Oncology Spaces – developments in neurodegenerative, inflammatory, and infectious diseases
Day 3
From Strategy to Delivery: Aligning Bioanalytical Innovation and Execution Across Clinical Phases
A Universal AI Design Framework and Brokerage Platform for Democratised Manufacturing of mRNA Therapeutics
Spatial Transcriptomics in Solid Tumor Immunology
Evolving trends in biosimilar clinical trials
The start-to-finish of biologics
The Festival of Biologics brings together pharma & biotech, academics, research institutes, regulators, patients groups and payers together with their partners across the value chain to bring you from discovery to market.
Content Themes
DISEASE AREAS
Oncology
Chronic and acute inflammation
Autoimmune diseases
Infectious diseases
Neurodegenerative diseases
THERAPIES
Antibody formats (mAbs, Bispecifics, ADCs)
Cell therapy
Gene therapy
Vaccines
Precision medicine
Checkpoint inhibition
Combination therapies
Biosimilars
DISCOVERY
Protein expression & discovery
Target identification
Lead screening
Optimisation methods
Antibody expression
AI for discovery
DEVELOPMENT
Protein engineering
Gene engineering
Analytics
Immunogenicity
AI and computational tools
CMC
Biomarkers
Tumor Microenvironment
Biosimilars
CLINICAL TRIALS OPERATIONS
Trial design
Patient recruitment
Digital/data systems
Site selection
Regulation
Real world evidence
AI
Wearables
MANUFACTURING
Upstream processing
Downstream processing
Formulation
Purification
Cell line development
Biosimilar manufacturing
FILL & FINISH AND LOGISTICS
Injectables
Aseptic fill
Freeze drying
Shipping systems
Global and local supply chain management
FINANCE AND INVESTMENT
Seed investment
Licensing
Mergers and acquisitions
VC and accelerator funding
Global investment landscape
COMMERCIALISATION AND MARKET ACCESS
Get to market
Regulatory environment
Biosimilar commercialisation
Market sustainability
DIAGNOSTICS
Companion Diagnostics
Molecular Diagnostics
Biomarker Analysis
In Vivo Techniques
Diagnostic Devices
“High scientific level and good networking opportunity”
– Principal Expert, Sartorius
“Good variety of talks and topics to cater to several different audience”
– Scientist, Celonic AG
"A very high-quality meeting at a great conference venue, with excellent talks, networking opportunities and forums for discussing topical industry issues”
– Product Manager, Proteins and Antibodies, Bio-Techne
– Product Manager, Proteins and Antibodies, Bio-Techne
“Very wide audience and a perfect venue to connect with opinion leaders, investors and scientists”
- LSMS / Pharma / BioPharma EMEA, Bruker Daltonics GmbH & Co. KG
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events